AU7263300A - Opaminergic neuronal survival-promoting factors and uses thereof - Google Patents

Opaminergic neuronal survival-promoting factors and uses thereof

Info

Publication number
AU7263300A
AU7263300A AU72633/00A AU7263300A AU7263300A AU 7263300 A AU7263300 A AU 7263300A AU 72633/00 A AU72633/00 A AU 72633/00A AU 7263300 A AU7263300 A AU 7263300A AU 7263300 A AU7263300 A AU 7263300A
Authority
AU
Australia
Prior art keywords
opaminergic
neuronal survival
promoting factors
promoting
factors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72633/00A
Other languages
English (en)
Inventor
John Commissiong
Andrei A. Raibekas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEUROTROPHIC BIOSCIENCE Inc
Original Assignee
NEUROTROPHIC BIOSCIENCE Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEUROTROPHIC BIOSCIENCE Inc filed Critical NEUROTROPHIC BIOSCIENCE Inc
Publication of AU7263300A publication Critical patent/AU7263300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/08—Coculture with; Conditioned medium produced by cells of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Psychology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU72633/00A 1999-09-16 2000-09-18 Opaminergic neuronal survival-promoting factors and uses thereof Abandoned AU7263300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15466899P 1999-09-16 1999-09-16
US60/154668 1999-09-16
PCT/CA2000/001049 WO2001019851A2 (fr) 1999-09-16 2000-09-18 Facteurs stimulant la survie de neurones dopaminergiques et leur utilisation

Publications (1)

Publication Number Publication Date
AU7263300A true AU7263300A (en) 2001-04-17

Family

ID=22552259

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72633/00A Abandoned AU7263300A (en) 1999-09-16 2000-09-18 Opaminergic neuronal survival-promoting factors and uses thereof

Country Status (6)

Country Link
EP (1) EP1220681A2 (fr)
JP (1) JP2003511352A (fr)
AU (1) AU7263300A (fr)
CA (1) CA2383076A1 (fr)
MX (1) MXPA02002765A (fr)
WO (1) WO2001019851A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5091201A (en) * 2000-03-21 2001-10-03 Curagen Corp Vegf-modulated genes and methods employing them
EP1373502B8 (fr) 2001-03-20 2010-12-22 Amarantus Therapeutics, Inc. Facteurs promoteurs de la survie des neurones dopaminergiques et utilisations associees
US7452969B2 (en) 2002-08-30 2008-11-18 Licentia Ltd Neurotrophic factor protein and uses thereof
EP1644406B1 (fr) 2003-07-11 2012-08-15 DeveloGen Aktiengesellschaft Utilisation de produits des proteines dg153 secretees pour la prevention et le traitement de maladies du pancreas et/ou de l'obesite et/ou du syndrome metabolique
DE602005023550D1 (de) 2005-12-14 2010-10-21 Licentia Ltd Verwendungen eines neurotrophischen Faktors
FI20080326A0 (fi) 2008-04-30 2008-04-30 Licentia Oy Neurotroofinen tekijä MANF ja sen käytöt
GB0908934D0 (en) * 2009-05-26 2009-07-01 Univ The West Of Scotland Differentiation medium
WO2015149005A1 (fr) * 2014-03-28 2015-10-01 Buck Institute For Research On Aging Méthodes et compositions pour moduler le système immunitaire

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1219839B (it) * 1988-02-08 1990-05-24 Fidia Farmaceutici Purificazione,caratterizazione e applicazione di un fattore neuronotrofico derivato da cervello di nammifero
US5229500A (en) * 1989-08-30 1993-07-20 Regeneron Pharmaceuticals, Inc. Brain derived neurotrophic factor
DE69334344D1 (de) * 1992-10-28 2010-11-18 Neurospheres Holding Ltd Biologische Faktoren und neuronale Stammzellen
WO1996033731A1 (fr) * 1995-04-26 1996-10-31 Regeneron Pharmaceuticals, Inc. Procedes d'utilisation des facteurs neurotrophiques pour faciliter les greffes de neurones
US6222022B1 (en) * 1996-03-14 2001-04-24 Washington University Persephin and related growth factors

Also Published As

Publication number Publication date
WO2001019851A2 (fr) 2001-03-22
EP1220681A2 (fr) 2002-07-10
CA2383076A1 (fr) 2001-03-22
JP2003511352A (ja) 2003-03-25
MXPA02002765A (es) 2005-09-08
WO2001019851A3 (fr) 2001-09-20

Similar Documents

Publication Publication Date Title
AU4208799A (en) Interleukins-21 and 22
AU6241698A (en) Tace-like and matrilysin-like polypeptides
AU4161899A (en) Radiotherapeutical device and use thereof
AU7687298A (en) Dihydropyrimidines and uses thereof
AU9781998A (en) Huchordin and uses thereof
AU1540001A (en) Fluorene-perylene copolymers and uses thereof
AU7612000A (en) Mono- and bis-indolylquinones and prophylactic and therapeutic uses thereof
AU3753599A (en) Micro-compartmentalization device and uses thereof
AU4198299A (en) Compounds and uses thereof
AU6636598A (en) Novel 3,4-dialkoxyphenyl derivatives and the use thereof
AU7073800A (en) Novel plexins and uses thereof
HUP0001603A3 (en) Cycloalkylalkanecarboxamides and the production and use thereof
AU2841801A (en) Triazolotriazinones and the use thereof
AU2418499A (en) Org-5222 in the treatment of depression
AU4776800A (en) Acetylcholinesterase-derived peptides and uses thereof
AU7263300A (en) Opaminergic neuronal survival-promoting factors and uses thereof
AU8695298A (en) Compounds and uses thereof
AU8486098A (en) Waterproof connector and waterproofing-housing member used in the same
AU6277699A (en) Guarantee 20
AU2399601A (en) Novel tachykinin-like polypeptides and use thereof
AU4629399A (en) Substituted piperazones and their therapeutic uses
AU5979300A (en) Angiopoietin-6 and uses thereof
AU2669201A (en) Taccalonolides and their use
AU3086200A (en) Eyesight-correction and/or eye-training device
AU4805399A (en) Connecting device and connecting fitting

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase